- China Tower’s net income for the fiscal year met estimates, reaching 9.75 billion yuan. The estimate was 9.68 billion yuan.
- The operating revenue was 94.01 billion yuan, just shy of the estimated 94.29 billion yuan.
- Revenue from the tower business hit 75.02 billion yuan, which was slightly lower than the estimated 75.32 billion yuan.
- Capital expenditure amounted to 31.72 billion yuan.
- A final dividend per share was announced at 3.7390 RMB cents.
- Investor sentiment appears mixed with 10 buys, 8 holds and 1 sell.
A look at China Tower Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
The long-term outlook for China Tower looks promising, as indicated by its Smartkarma Smart Scores. With a perfect score of 5 in both Value and Dividend, the company is financially sound and offers attractive returns to its shareholders. In terms of Growth, China Tower scores a solid 4, suggesting that the company has potential for expansion and development in the future. However, the company’s Resilience score of 2 indicates that it may face some challenges in the face of market volatility or economic downturns. Nevertheless, China Tower’s impressive Momentum score of 5 suggests that the company is performing well and is on an upward trajectory.
China Tower is a telecommunication company that operates throughout China, providing services such as tower construction, maintenance, and management. The company’s strong Smartkarma Smart Scores reflect its solid financial standing, potential for growth, and positive momentum. However, its lower Resilience score may point to potential risks in the future. Overall, with its impressive scores, China Tower is well-positioned for long-term success in the Chinese market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
